218 related articles for article (PubMed ID: 15663564)
1. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro.
Asano K; Kanai KI; Suzaki H
Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564
[TBL] [Abstract][Full Text] [Related]
2. Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.
Shimizu T; Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2005 Aug; 2005(3):150-9. PubMed ID: 16106101
[TBL] [Abstract][Full Text] [Related]
3. Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo.
Asano K; Kanai K; Furuta A; Furuya A; Suzaki H; Hisamitsu T
J Pharm Pharmacol; 2007 Oct; 59(10):1389-95. PubMed ID: 17910814
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis.
Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL
J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106
[TBL] [Abstract][Full Text] [Related]
5. Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro.
Asano K; Kanai K; Suzaki H
Arzneimittelforschung; 2004; 54(8):436-43. PubMed ID: 15460210
[TBL] [Abstract][Full Text] [Related]
6. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro.
Shimizu T; Kanai K; Kyo Y; Asano K; Hisamitsu T; Suzaki H
J Pharm Pharmacol; 2006 Jan; 58(1):91-9. PubMed ID: 16393468
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of fluticasone propionate on MMP expression in the nasal mucosa of allergic rhinitis patients in vivo.
Kyo Y; Kanai K; Asano K; Hisamitsu T; Suzaki H
In Vivo; 2006; 20(4):439-44. PubMed ID: 16900772
[TBL] [Abstract][Full Text] [Related]
8. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
9. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro.
Namba M; Asano K; Kanai K; Kyo Y; Watanabe S; Hisamitsu T; Suzaki H
Acta Otolaryngol; 2004 Oct; 124(8):964-9. PubMed ID: 15513534
[TBL] [Abstract][Full Text] [Related]
10. Suppressive activity of fexofenadine hydrochloride on thymus- and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro.
Asano K; Kanai K; Suzaki H
Int Arch Allergy Immunol; 2004 Mar; 133(3):267-75. PubMed ID: 14976396
[TBL] [Abstract][Full Text] [Related]
11. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
13. Nonasthmatic nasal polyposis patients with allergy exhibit greater epithelial MMP positivity.
Shin HW; Han DH; Lim YS; Kim HJ; Kim DY; Lee CH; Min YG; Rhee CS
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):442-7. PubMed ID: 19786210
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride.
Nogaki T; Asano K; Furuta A; Kanai K; Suzaki I; Kanei A; Suzaki H
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):139-45. PubMed ID: 22830293
[TBL] [Abstract][Full Text] [Related]
15. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C.
Domeij H; Modéer T; Yucel-Lindberg T
J Periodontal Res; 2004 Oct; 39(5):308-14. PubMed ID: 15324351
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.
Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E
J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333
[TBL] [Abstract][Full Text] [Related]
18. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta and tumor necrosis factor-alpha have opposite effects on fibroblasts and epithelial cells during basement membrane formation.
Furuyama A; Hosokawa T; Mochitate K
Matrix Biol; 2008 Jun; 27(5):429-40. PubMed ID: 18434122
[TBL] [Abstract][Full Text] [Related]
20. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
